PTGS2 and colorectal cancer: Post-diagnosis regular aspirin use was associated with reduced colorectal cancer-specific and overall mortality, especially in patients with positive PTGS2 (COX-2) expression and mutated PIK3CA tumors, reported by a meta-analysis (Li et al., 2015).